Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Cough
Interventions
DRUG

superior laryngeal nerve block

A unilateral injection of 2 cc of a 1:1 mixture of 0.25% bupivacaine and Kenalog-40 via a 27 gauge needle to the thyrohyoid space (front of neck, just above larynx/voice box) via a 27 gauge needle to the thyrohyoid space (front of neck, just above larynx/voice box) on the side which exhibited most discomfort/tenderness/cough on palpation. If neither side was uncomfortable, the right side will be used.

Trial Locations (1)

35233

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER